Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.21315/mjms2021.28.1.17 http://scihub22266oqcxt.onion/10.21315/mjms2021.28.1.17 33679230!7909343!33679230     free     free     free       Malays+J+Med+Sci 2021 ; 28 (1): 122-124 Nephropedia Template TP {{tp|p=33679230|t=2021. Primum Non Nocere |pdf=|usr=}}{{33679230}} gab.com Text Primum Non Nocere JO: Malays J Med Sci http://www.kidney.de/pget.php?&tw=1&pmid=33679230 #FOAvip The coronavirus disease 2019 (COVID-19) pandemic is severe and has not shown any signs of warning up to today. Biotech companies around the world have raced to come up with an acceptable vaccine and recently two mRNA vaccines have received emergency usage authorisation from regulatory bodies in several countries. mRNA vaccines, which consist of a new and revolutionary technology have not been previously tested widely on humans. Medium- and long-term safety data are not available. While many experts seem to support the start of a mass vaccination campaign, others feel there are too many unknowns to embark on a mass vaccination campaign. Concerns include uncertainties about the long-term effects of foreign mRNA on human cellular physiology and the possibility of vaccine-enhanced disease severity, which may not be unlikely with the current disease presentation of COVID-19. Twit Text FOAVip Primum Non Nocere ????Malays J Med Sci http://www.kidney.de/pget.php?&tw=1&pmid=33679230 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33679230 #FOAvip English Wikipedia <ref>{{Cite pmid|33679230}}</ref> Primum Non Nocere #MMPMID33679230 Van Rostenberghe H Malays J Med Sci 2021[Feb]; 28 (1): 122-124 PMID33679230show ga The coronavirus disease 2019 (COVID-19) pandemic is severe and has not shown any signs of warning up to today. Biotech companies around the world have raced to come up with an acceptable vaccine and recently two mRNA vaccines have received emergency usage authorisation from regulatory bodies in several countries. mRNA vaccines, which consist of a new and revolutionary technology have not been previously tested widely on humans. Medium- and long-term safety data are not available. While many experts seem to support the start of a mass vaccination campaign, others feel there are too many unknowns to embark on a mass vaccination campaign. Concerns include uncertainties about the long-term effects of foreign mRNA on human cellular physiology and the possibility of vaccine-enhanced disease severity, which may not be unlikely with the current disease presentation of COVID-19. äPrimum Non Nocere (epmc).pdf DeepDyve Pubget Overpricing